Dana R. Epstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dana R. Epstein has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Souraya Sidani
Daphne Cockwell School of Nursing, Ryerson University, Toronto, Ontario, Canada
5 shared publications - Mary T. Fox
Affiliations School of Nursing, York University, Toronto, Ontario, Canada, York University Centre for Aging Research and Education, Toronto, Ontario, Canada
3 shared publications - Joyal Miranda
School of Nursing, Ryerson University, 350 Victoria Street, Toronto, ON M5B 2 K3 Canada
2 shared publications - Patricia Moritz
School of Nursing, University of Colorado Health Sciences Center, Denver, CO, U.S.A.
2 shared publications - Souraya Sidani
Faculty of Nursing, University of Toronto, Ontario, Canada
2 shared publications - Andrea C. Hekler
Phoenix Veterans Affairs Health Care System, Phoenix, AZ, 85012, USA
1 shared publication
Latest Publications
- 9 November 2015
- Published by Oxford University Press (OUP) in Translational Behavioral Medicine
- Vol. 6 (3) , 438-448
BeWell24: development and process evaluation of a smartphone “app” to improve sleep, sedentary, and active behaviors in US Veterans with increased metabolic risk
Lifestyle behaviors across the 24-h spectrum (i.e., sleep, sedentary, and active behaviors) drive metabolic risk. We describe the development and pro
- 9 November 2015
- Published by Oxford University Press (OUP) in Translational Behavioral Medicine
- Vol. 6 (3) , 438-448
BeWell24: development and process evaluation of a smartphone “app” to improve sleep, sedentary, and active behaviors in US Veterans with increased metabolic risk
Lifestyle behaviors across the 24-h spectrum (i.e., sleep, sedentary, and active behaviors) drive metabolic risk. We describe the development and pro
- Open Access
- 9 November 2015
- Published by Springer Nature in BMC Nursing
- Vol. 14 (1) , 1-8
Examining the influence of treatment preferences on attrition, adherence and outcomes: a protocol for a two-stage partially randomized trial
Empirical evidence pertaining to the influence of treatment preferences on attrition, adherence and outcomes in intervention evaluation trials is inconsistent. The inconsistency can be explained by the method used for allocating treatment and measuring preferences. The current methodological study is designed to address these factors by implementing the two-stage partially randomized or preference trial design, and administering a validated measure to assess participants’ preferences for the treatments under evaluation. It aims to compare attrition, adherence and outcomes for participants allocated randomly or by preference to treatment. The study is in its final stages of data collection; its protocol is presented in this paper. A partially randomized clinical or preference trial is used. Eligible participants are randomized to two trial arms. First is the random arm involving random assignment to treatments, and second is the preference arm involving allocation to the chosen treatment. Participants with chronic insomnia are targeted. Two behavioral treatments are offered, stimulus control therapy and sleep restriction therapy, in the same format (small group) and dose (two sessions given over a 4-week period). A participant log is used to collect data on attrition. Adherence is evaluated in terms of exposure and enactment of treatment. Sleep-related outcomes (sleep parameters and perceived insomnia severity) are measured at pretest, posttest, 6 and 12 month follow-up. Treatment preferences, adherence and outcomes are assessed with reliable and valid measures. The advantages and limitations of the preference trial design are highlighted. The challenges in implementing the trial are discussed relative to the distribution of participants in the groups defined by treatment received and method of treatment allocation. ClinicalTrials.gov Registry NCT02513017
- 9 November 2015
- Published by Springer Nature in BMC Nursing
- Vol. 14 (1) , 1-8
Open AccessExamining the influence of treatment preferences on attrition, adherence and outcomes: a protocol for a two-stage partially randomized trial
Empirical evidence pertaining to the influence of treatment preferences on attrition, adherence and outcomes in intervention evaluation trials is inconsistent. The inconsistency can be explained by the method used for allocating treatment and measuring preferences. The current methodological study is designed to address these factors by implementing the two-stage partially randomized or preference trial design, and administering a validated measure to assess participants’ preferences for the treatments under evaluation. It aims to compare attrition, adherence and outcomes for participants allocated randomly or by preference to treatment. The study is in its final stages of data collection; its protocol is presented in this paper. A partially randomized clinical or preference trial is used. Eligible participants are randomized to two trial arms. First is the random arm involving random assignment to treatments, and second is the preference arm involving allocation to the chosen treatment. Participants with chronic insomnia are targeted. Two behavioral treatments are offered, stimulus control therapy and sleep restriction therapy, in the same format (small group) and dose (two sessions given over a 4-week period). A participant log is used to collect data on attrition. Adherence is evaluated in terms of exposure and enactment of treatment. Sleep-related outcomes (sleep parameters and perceived insomnia severity) are measured at pretest, posttest, 6 and 12 month follow-up. Treatment preferences, adherence and outcomes are assessed with reliable and valid measures. The advantages and limitations of the preference trial design are highlighted. The challenges in implementing the trial are discussed relative to the distribution of participants in the groups defined by treatment received and method of treatment allocation. ClinicalTrials.gov Registry NCT02513017
- 23 July 2015
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 23 (1) , 14-20
Contribution of treatment acceptability to acceptance of randomization: an exploration
The study findings indicated that participants are likely to express unwillingness to be randomized once they receive treatment information and rate the acceptability of treatments. The reported non-acceptance may influence participants' behaviour (e.g. withdrawal, non-adherence) during the trial, suggesting the need to explore alternative designs for intervention evaluation.
- 23 July 2015
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 23 (1) , 14-20
Contribution of treatment acceptability to acceptance of randomization: an exploration
The study findings indicated that participants are likely to express unwillingness to be randomized once they receive treatment information and rate the acceptability of treatments. The reported non-acceptance may influence participants' behaviour (e.g. withdrawal, non-adherence) during the trial, suggesting the need to explore alternative designs for intervention evaluation.
- 1 May 2015
- Published by Elsevier in International Journal of Nursing Studies
- Vol. 52 (5) , 1017-1024
Conducting a two-stage preference trial: Utility and challenges
- 1 May 2015
- Published by Elsevier in International Journal of Nursing Studies
- Vol. 52 (5) , 1017-1024
Conducting a two-stage preference trial: Utility and challenges
- 20 March 2015
- Published by Taylor & Francis in Journal of Evidence-Informed Social Work
- Vol. 12 (5) , 451-461
Effects of a Multi-Component Behavioral Intervention (MCI) for Insomnia on Depressive and Insomnia Symptoms in Individuals with High and Low Depression
Insomnia and depression are prevalent and co-occurring conditions that are associated with significant impairment of life. Previous research indicates that cognitive-behavioral interventions for insomnia (CBT-I) can improve both insomnia and depressive symptoms. The aim of the authors in this study was to determine whether a multi-component behavioral intervention (MCI) improved both insomnia and depressive symptoms in persons presenting with insomnia and high levels of depression. The sample consisted of 321 individuals with insomnia who participated in a trial of insomnia treatments; 106 participants had high levels of depression (score ≥ 16 on CES-D) at baseline. Participants either received the MCI or a control treatment (sleep education and hygiene booklet). At post-test, participants with high and low levels of depressive symptoms showed significant improvement in insomnia symptoms. Those with high depression also had significant reductions in depressive symptoms. It can be concluded that for individuals with depression and insomnia, CBT-I is a viable intervention for managing depressive symptoms, which complements other approaches for treating depression.
- 20 March 2015
- Published by Taylor & Francis in Journal of Evidence-Informed Social Work
- Vol. 12 (5) , 451-461
Effects of a Multi-Component Behavioral Intervention (MCI) for Insomnia on Depressive and Insomnia Symptoms in Individuals with High and Low Depression
Insomnia and depression are prevalent and co-occurring conditions that are associated with significant impairment of life. Previous research indicates that cognitive-behavioral interventions for insomnia (CBT-I) can improve both insomnia and depressive symptoms. The aim of the authors in this study was to determine whether a multi-component behavioral intervention (MCI) improved both insomnia and depressive symptoms in persons presenting with insomnia and high levels of depression. The sample consisted of 321 individuals with insomnia who participated in a trial of insomnia treatments; 106 participants had high levels of depression (score ≥ 16 on CES-D) at baseline. Participants either received the MCI or a control treatment (sleep education and hygiene booklet). At post-test, participants with high and low levels of depressive symptoms showed significant improvement in insomnia symptoms. Those with high depression also had significant reductions in depressive symptoms. It can be concluded that for individuals with depression and insomnia, CBT-I is a viable intervention for managing depressive symptoms, which complements other approaches for treating depression.
- 1 June 2012
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 35 (6) , 797-805
Dismantling Multicomponent Behavioral Treatment for Insomnia in Older Adults: A Randomized Controlled Trial
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.
- 1 June 2012
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 35 (6) , 797-805
Dismantling Multicomponent Behavioral Treatment for Insomnia in Older Adults: A Randomized Controlled Trial
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.
- 1 January 2012
- Published by Journal of Rehabilitation Research & Development in Journal of Rehabilitation Research and Development
- Vol. 49 (6) , 867-78
Insomnia treatment acceptability and preferences of male Iraq and Afghanistan combat Veterans and their healthcare providers
Sleep difficulty is a prevalent problem among returning Veterans. Although there is strong evidence for the efficacy and durability of cognitive-behavioral treatment for insomnia (CBT-I) in the general population, the interventions require motivation, attention, and adherence from patients to achieve successful outcomes. Given the unique characteristics of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans who have experienced blast-related injuries and other trauma, CBT-I for these patients may require modification, including alternative delivery methods, to ensure effective implementation and positive outcomes. We interviewed 18 OIF/OEF Veterans who screened positive for mild traumatic brain injury and 19 healthcare providers to determine the acceptability of insomnia treatments and preferences for the interventions and treatment delivery. Veterans and providers had distinct preferences for insomnia treatment and its delivery. The treatments the Veterans found most acceptable were also the ones they preferred: relaxation treatment and pharmacotherapy. The providers identified relaxation therapy as the most acceptable treatment. Veterans preferred the individual treatment format as well as electronic methods of treatment delivery. Despite some differences between patients and providers, a compromise through modification of empirically supported behavioral treatments is feasible, and implications for preference-based insomnia intervention development and testing are discussed.
- 1 January 2012
- Published by Journal of Rehabilitation Research & Development in Journal of Rehabilitation Research and Development
- Vol. 49 (6) , 867-78
Insomnia treatment acceptability and preferences of male Iraq and Afghanistan combat Veterans and their healthcare providers
Sleep difficulty is a prevalent problem among returning Veterans. Although there is strong evidence for the efficacy and durability of cognitive-behavioral treatment for insomnia (CBT-I) in the general population, the interventions require motivation, attention, and adherence from patients to achieve successful outcomes. Given the unique characteristics of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Veterans who have experienced blast-related injuries and other trauma, CBT-I for these patients may require modification, including alternative delivery methods, to ensure effective implementation and positive outcomes. We interviewed 18 OIF/OEF Veterans who screened positive for mild traumatic brain injury and 19 healthcare providers to determine the acceptability of insomnia treatments and preferences for the interventions and treatment delivery. Veterans and providers had distinct preferences for insomnia treatment and its delivery. The treatments the Veterans found most acceptable were also the ones they preferred: relaxation treatment and pharmacotherapy. The providers identified relaxation therapy as the most acceptable treatment. Veterans preferred the individual treatment format as well as electronic methods of treatment delivery. Despite some differences between patients and providers, a compromise through modification of empirically supported behavioral treatments is feasible, and implications for preference-based insomnia intervention development and testing are discussed.
- 1 January 2011
- Published by American Psychological Association (APA)
An Expert Perspective of Errors in Endoscope Reprocessing
- 1 January 2011
- Published by American Psychological Association (APA)
An Expert Perspective of Errors in Endoscope Reprocessing
- 1 October 2009
- Published by Elsevier in Behaviour Research and Therapy
- Vol. 47 (10) , 823-829
Relationships between personal beliefs and treatment acceptability, and preferences for behavioral treatments
- 1 October 2009
- Published by Elsevier in Behaviour Research and Therapy
- Vol. 47 (10) , 823-829
Relationships between personal beliefs and treatment acceptability, and preferences for behavioral treatments
- 1 September 2009
- Published by Wolters Kluwer Health in Cancer Nursing
- Vol. 32 (5) , 404-411
Fatigue-Based Subgroups of Breast Cancer Survivors With Insomnia
The purpose of this study was to determine if breast cancer survivors (BCS) with insomnia can be grouped according to their level of fatigue. A secondary data analysis was conducted on baseline data obtained from a randomized clinical trial that focused on a cognitive-behavioral intervention for insomnia in BCS. Participants were BCS (n = 86) with insomnia who were at least 3 months after completion of primary treatment without current evidence of disease. Three subgroups of women were identified with significant differences in fatigue, including exhausted (35%), tired (41%), and restored (24%). Results suggest that most women have moderate to severe fatigue many years after completion of treatment. Severe fatigue was associated with higher levels of other symptoms and poorer quality of life (exhausted subgroup). Significant differences in insomnia severity, anxiety, depression, and quality of life were noted among the exhausted, tired, and restored subgroups. The existence of fatigue-based subgroups offers important information when providing care to BCS. By determining symptoms associated with fatigue, patient care will benefit through a shift in focus from treatment of a single symptom such as fatigue to the delivery of a tailored intervention that targets multiple symptoms.
- 1 September 2009
- Published by Wolters Kluwer Health in Cancer Nursing
- Vol. 32 (5) , 404-411
Fatigue-Based Subgroups of Breast Cancer Survivors With Insomnia
The purpose of this study was to determine if breast cancer survivors (BCS) with insomnia can be grouped according to their level of fatigue. A secondary data analysis was conducted on baseline data obtained from a randomized clinical trial that focused on a cognitive-behavioral intervention for insomnia in BCS. Participants were BCS (n = 86) with insomnia who were at least 3 months after completion of primary treatment without current evidence of disease. Three subgroups of women were identified with significant differences in fatigue, including exhausted (35%), tired (41%), and restored (24%). Results suggest that most women have moderate to severe fatigue many years after completion of treatment. Severe fatigue was associated with higher levels of other symptoms and poorer quality of life (exhausted subgroup). Significant differences in insomnia severity, anxiety, depression, and quality of life were noted among the exhausted, tired, and restored subgroups. The existence of fatigue-based subgroups offers important information when providing care to BCS. By determining symptoms associated with fatigue, patient care will benefit through a shift in focus from treatment of a single symptom such as fatigue to the delivery of a tailored intervention that targets multiple symptoms.